The DOI matches its Crossref record; 65 of the 70 references it cites were found in a registry or an index.
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Open accessAbstract
p21CIP1/WAF1 is a CDK inhibitor regulated by the tumor suppressor p53 and is hypothesized to mediate G1 arrest. p53 has been suggested to derive anti-oncogenic properties from this relationship. To test these notions, we created mice lacking p21CIP1/WAF1. They develop normally and (unlike p53-/- mice) have not developed spontaneous malignancies during 7 months of observation. Nonetheless, p21-/- embryonic fibroblasts are significantly deficient in their ability to arrest in G1 in response to DNA damage and nucleotide pool perturbation. p21-/- cells also exhibit a significant growth alteration in vitro, achieving a saturation density as high as that observed in p53-/- cells. In contrast, other aspects of p53 function, such as thymocytic apoptosis and the mitotic spindle checkpoint, appear normal. These results establish the role of p21CIP1/WAF1 in the G1 checkpoint, but suggest that the anti-apoptotic and the anti-oncogenic effects of p53 are more complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p21 is required for p53-mediated G1/S146, 147, 148 and also for G2/M cell cycle arrest.149”
From Census and evaluation of p53 target genes (2017) · cites this paper as [148]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Inhibitors of mammalian G1 cyclin-dependent kinases.Preprint
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,242
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Research works printed but not linked: 3
- Jiang, 1994, Induction of differentiation in human promyelocytic HL60 leukemia cells activates p21WAF1/CIP1 expression in the absence of p53, Oncogene, 9, 3397
- Steinman, 1994, Induction of p21 (WAFf1CIPl) during differentiation, Oncogene, 9, 3389
- Strasser, 1993, Eubcl2 transgene facilitates spontaneaous transformation of early pre-B and Ig secreting cells but not T cells, Oncogene, 8, 1
Cited by
Sorted by citations
Items 801–900 of 1,008
Alagbala, A. A., McRiner, A. J., Borstnik, K., Labonte, T., Chang, W., D’Angelo, J. G., Posner, G. H., & Foster, B. A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060803i · Cited by 66
Yang, K. G., Zheng, X., Qin, J., Wang, Y., Bai, Y., Mao, Q., Wan, Q., Wu, Z., & Xie, L. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.014 · Cited by 66
CDKs and cyclins in transition(s)
Fisher, R. P. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80106-2 · Cited by 66
Wible, B. A., Wang, L., Kuryshev, Y. A., Basu, A., Haldar, S., & Brown, A. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201689200 · Cited by 66
Ruesch, M. N., & Laimins, L. A. (1998) · Virology · doi:10.1006/viro.1998.9359 · Cited by 66
Liu, M., Wikonkál, N. M., & Brash, D. E. (1999) · Carcinogenesis · doi:10.1093/carcin/20.9.1869 · Cited by 66
Aguilar‐Lemarroy, A., Gariglio, P., Whitaker, N. J., Eichhorst, S. T., Hausen, H. Z., Krammer, P. H., & Rösl, F. (2002) · Oncogene · doi:10.1038/sj.onc.1204979 · Cited by 66
Higgy, N. A., Salicioni, A. M., Russo, I. H., Zhang, P. L., & Russo, J. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199712)20:4 · Cited by 40
Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development
Staheli, J. P., Kim, K.-H., Liggitt, D., Gurley, K. E., Longton, G., & Kemp, C. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207220 · Cited by 66
Shou, W., & Dunphy, W. G. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.3.457 · Cited by 67
The primary enamel knot determines the position of the first buccal cusp in developing mice molars
Cho, S. W., Lee, H.-A., Cai, J., Lee, M.-J., Kim, J., Ohshima, H., & Jung, H.-S. (2007) · Differentiation · doi:10.1111/j.1432-0436.2006.00153.x · Cited by 65
p27 Kip1 Inhibition of GRB2-SOS Formation Can Regulate Ras Activation
Moeller, S. J., Head, E. D., & Sheaff, R. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.11.3735-3752.2003 · Cited by 65
Ferretti, A. C., Tonucci, F. M., Hidalgo, F., Almada, E., Larocca, M. C., & Favre, C. (2016) · Oncotarget · doi:10.18632/oncotarget.7404 · Cited by 64
Purbey, P. K., Scumpia, P. O., Kim, P. J., Tong, A.-J., Iwamoto, K. S., McBride, W. H., & Smale, S. T. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.017 · Cited by 66
Mutoh, M., Lung, F. ‐. T., Long, Y. Q., Roller, P. P., Sikorski, R. S., & O'Connor, P. M. (1999) · PubMed · doi:10.11501/3170955 · Cited by 65
Corpus Luteum Development: Lessons from Genetic Models in Mice
Bachelot, A., & Binart, N. (2005) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)68003-9 · Cited by 65
Regulation of macrophage activation and septic shock susceptibility via p21(WAF1/CIP1)
Trakala, M., Fernández-Arias, C., García, M. I., Moreno-Ortiz, M. C., Tsilingiri, K., Fernández-Marcos, P. J., Mellado, M., Díaz-Meco, M. T., Moscat, J., Serrano, M., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200838676 · Cited by 65
Lawson, B. R., Baccalà, R., Song, J. J., Croft, M., Kono, D. H., & Theofilopoulos, A. N. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031685 · Cited by 65
Li, B., & Lee, M. Y. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101167200 · Cited by 65
The axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells
Chen, C., Liu, Y., Liu, Y., & Zheng, P. (2009) · Cell Cycle · doi:10.4161/cc.8.8.8139 · Cited by 67
Zhang, Y., Gao, Y., Zhang, G., Huang, S., Dong, Z., Kong, C., Su, D., Du, J., Zhu, S., Liang, Q. Y., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25365 · Cited by 64
Identification of Tcf-4 as a transcriptional target of p53 signalling
Rother, K., Johne, C., Spiesbach, K., Haugwitz, U., Tschöp, K., Wasner, M., Klein‐Hitpaß, L., Möröy, T., Mössner, J., & Engeland, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207464 · Cited by 65
Weinberg, W. C., Fernández‐Salas, E., Morgan, D. L., Shalizi, A., Mirosh, E., Stanulis, E., Deng, C., Hennings, H., & Yuspa, S. H. (1999) · PubMed · Cited by 64
Self-citationCormier, R. T., & Dove, W. F. (2000) · PubMed · Cited by 64
Cell-cycle regulation in immunity, tolerance and autoimmunity
Balomenos, D., & Martínez‐A, C. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01748-5 · Cited by 64
Vernon, A. E., & Philpott, A. (2002) · Development · doi:10.1242/dev.00180 · Cited by 64
Kramer, J. L., Baltathakis, I., Alcantara, O., & Boldt, D. H. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03498.x · Cited by 64
Jirawatnotai, S., Moons, D. S., Stocco, C. O., Franks, R. R., Hales, D. B., Gibori, G., & Kiyokawa, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301206200 · Cited by 64
Ruesch, M. N., & Laimins, L. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5570-5578.1997 · Cited by 64
From DNA damage to cell cycle arrest and suicide: a budding yeast perspective
Lydall, D. A., & Weinert, T. A. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)90003-9 · Cited by 64
Dnmt1 is essential to maintain progenitors in the perinatal intestinal epithelium
Elliott, E. N., Sheaffer, K. L., Schug, J., Stappenbeck, T. S., & Kaestner, K. H. (2015) · Development · doi:10.1242/dev.117341 · Cited by 63
Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer
Bauer, J. I., Özden, Ö., Akagi, N., Carroll, T. P., Principe, D. R., Staudacher, J. J., Spehlmann, M. E., Eckmann, L., Grippo, P. J., & Jung, B. H. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0456-4 · Cited by 63
Cell Cycle Dysregulation in Pituitary Oncogenesis
Musat, M., Vax, V., Borboli, N., Gueorguiev, M., Bonner, S., Korbonits, M., & Grossman, A. B. (2004) · KARGER eBooks · doi:10.1159/000079037 · Cited by 63
AMF1 (GPS2) Modulates p53 Transactivation
Peng, Y., Kuo, F., Breiding, D. E., Wang, Y., Mansur, C. P., & Androphy, E. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5913-5924.2001 · Cited by 62
Liu, Y., Bohn, S. A., & Sherley, J. L. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.1.15 · Cited by 63
Aiello, F., Carullo, G., Giordano, F., Spina, E., Nigro, A., Garofalo, A., Tassini, S., Costantino, G., Vincetti, P., Bruno, A., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700145 · Cited by 62
Danziger, O., Patel, R. S., DeGrace, E. J., Rosen, M. R., & Rosenberg, B. R. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010464 · Cited by 62
Induction of genetic instability by gain-of-function p53 cancer mutants
Xu, Y. (2008) · Oncogene · doi:10.1038/sj.onc.1211023 · Cited by 63
Georgopoulou, N., Hurel, C., Politis, P. K., Gaitanou, M., Matsas, R., & Thomaidou, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602689200 · Cited by 61
Curcumin inhibits the proliferation and mineralization of cultured osteoblasts
Notoya, M., Nishimura, H., Woo, J., Nagai, K., Ishihara, Y., & Hagiwara, H. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.01.028 · Cited by 62
p21Waf1/Cip1 plays a critical role in modulating senescence through changes of DNA methylation
Zheng, Q. H., Li, W., Zhu, W., Zhang, Z. Y., & Tong, T. J. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20838 · Cited by 62
Giono, L. E., & Manfredi, J. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01967-06 · Cited by 62
Idogawa, M., Sasaki, Y., Suzuki, H., Mita, H., Imai, K., Shinomura, Y., & Tokino, T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2396 · Cited by 62
Hulmi, J., Nissinen, T., Räsänen, M., Degerman, J., Lautaoja, J. H., Hemanthakumar, K. A., Backman, J., Ritvos, O., Silvennoinen, M., & Kivelä, R. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12265 · Cited by 55
Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells
Honma, M. (2005) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20113 · Cited by 64
Ogasawara, T., Katagiri, M., Yamamoto, A., Hoshi, K., Takato, T., Nakamura, K., Tanaka, S., Okayama, H., & Kawaguchi, H. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2004.19.7.1128 · Cited by 62
Messina, G., Blasi, C., Rocca, S. A. L., Pompili, M., Calconi, A., & Grossi, M. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-07-0612 · Cited by 62
Accumulation of p21Cip1/WAF1 during Hyperoxic Lung Injury in Mice
O’Reilly, M. A., Staversky, R. J., Watkins, R. H., & Maniscalco, W. M. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.5.3200 · Cited by 62
Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss, D. J., Lee, R. J., Troyer, D. A., Pestell, R. G., & Windle, J. J. (2002) · PubMed · Cited by 62
Sax, J. K., & El-Deiry, W. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303191200 · Cited by 60
A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic Implications
Wang, M., & Attardi, L. D. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-025840 · Cited by 61
Growth inhibition and apoptosis induction by tanshinone I in human colon cancer Colo 205 cells
Su, C. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000063 · Cited by 61
CYTOLETHAL DISTENDING TOXIN (CDT): GENETIC DIVERSITY, STRUCTURE AND ROLE IN DIARRHEAL DISEASE
Yamasaki, S., Asakura, M., Tsukamoto, T., Faruque, S. M., Deb, R., & Ramamurthy, T. (2006) · Toxin Reviews · doi:10.1080/15569540500320938 · Cited by 61
The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO
Peterson, L. F., Yan, M., & Zhang, D. (2007) · Blood · doi:10.1182/blood-2006-03-012575 · Cited by 61
Neuronal Development of Embryonic Stem Cells: A Model of GABAergic Neuron Differentiation
Westmoreland, J. J., Hancock, C. R., & Condie, B. G. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5031 · Cited by 61
Mueller, S., Cadenas, E., & Schönthal, A. H. (2000) · PubMed · Cited by 61
Apoptosis in tumorigenesis and cancer therapy
Fisher, D. E. (1997) · Frontiers in bioscience · doi:10.2741/a197 · Cited by 61
Saintigny, Y., & López, B. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205040 · Cited by 61
Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios
Su, C. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000030 · Cited by 60
Hoeferlin, L. A., Oleinik, N. V., Krupenko, N. I., & Krupenko, S. A. (2011) · Genes & Cancer · doi:10.1177/1947601911432495 · Cited by 59
Culture and transplantation of spermatogonial stem cells
Takashima, S., & Shinohara, T. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.03.006 · Cited by 60
Chen, L., Li, J., Fan, Y., Qiu, J., Cao, L., Laurent, R., Mignani, S. M., Caminade, A., Majoral, J., & Shi, X. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00458 · Cited by 61
Tumor formation in Brca1 conditional mutant mice
Deng, C. (2002) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10069 · Cited by 60
Self-citationDietz, S., Rother, K., Bamberger, C., Schmale, H., Mössner, J., & Engeland, K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03093-4 · Cited by 60
NS1- and Minute Virus of Mice-Induced Cell Cycle Arrest: Involvement of p53 and p21 cip1
Beeck, A. O. D., Sobczak‐Thépot, J., Sirma, H., Bourgain‐Guglielmetti, F., Bréchot, C., & Caillet-Fauquet, P. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.11071-11078.2001 · Cited by 59
Cytokine-Stimulated T Lymphocyte Proliferation Is Regulated by p27Kip1 1
Zhang, S., Lawless, V. A., & Kaplan, M. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6270 · Cited by 60
Probing protein structure using biochemical and biophysical methods
Kriwacki, R. W., Wu, J., Tennant, L. L., Wright, P. E., & Siuzdak, G. E. (1997) · Journal of Chromatography A · doi:10.1016/s0021-9673(97)00527-x · Cited by 60
Dai, M., Al-Odaini, A. A., Arakelian, A., Rabbani, S. A., Ali, S., & Lebrun, J. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3322 · Cited by 61
Wang, B., Liu, K., Lin, H., Bellam, N., Ling, S., & Lin, W.-C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01335-09 · Cited by 59
P21(Cip1/WAF1) expression in the mouse testis before and after X irradiation
Beumer, T. L., Roepers‐Gajadien, H. L., Gademan, I. S., Rutgers, D. H., & de Rooij, D. G. (1997) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199707)47:3 · Cited by 59
Cyclin-Dependent Kinase Inhibitors in Yeast, Animals, and Plants: A Functional Comparison
Clercq, A. D., & Inzé, D. (2006) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230600856685 · Cited by 59
Hromas, R., Ye, H., Spinella, M. J., Dmitrovsky, E., Xu, D., & Costa, R. H. (1999) · Cell and Tissue Research · doi:10.1007/s004410051365 · Cited by 59
Vaziri, H., & Benchimol, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203016 · Cited by 59
Burns, T. F., & El‐Deiry, W. S. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.4.478 · Cited by 59
Kachnic, L. A., Wu, B., Wunsch, H., Mekeel, K. L., DeFrank, J. S., Tang, W., & Powell, S. N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13111 · Cited by 59
Fernández-Arias, C., Ballesteros‐Tato, A., García, M. I., Martín‐Caballero, J., Flores, J. M., Martínez‐A, C., & Balomenos, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2296 · Cited by 59
Jin, G.-F., Hurst, J. S., & Godley, B. F. (2001) · Current Eye Research · doi:10.1076/ceyr.23.1.11.5423 · Cited by 58
Shigeoka, T. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni022 · Cited by 59
Down-Regulation of p27Kip1 Expression Is Required for Development and Function of T Cells
Tsukiyama, T., Ishida, N., Shirane, M., Minamishima, Y. A., Hatakeyama, S., Kitagawa, M., Nakayama, K., & Nakayama, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.304 · Cited by 58
Paradigms of Growth Control: Relation to Cdk Activation
Olashaw, N., & Pledger, W. J. (2002) · Science Signaling · doi:10.1126/stke.2002.134.re7 · Cited by 59
Lu, X., Magrane, G., Yin, C., Louis, D. N., Gray, J. W., & Dyke, T. V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.6017-6030.2001 · Cited by 55
DNA damage checkpoints: Implications for cancer therapy
O'Connor, P. M., & Fan, S. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_16 · Cited by 58
Induction of p21WAF/CIP1 during Hyperoxia
McGrath, S. A. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.2.2964m · Cited by 58
Huang, L., Clarkin, K., & Wahl, G. M. (1996) · PubMed · Cited by 58
Lim, D., Jocelyn, K. M.-X., Yip, G. W. C., & Bay, B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.038 · Cited by 58
Zalc, A., Hayashi, S., Aurade, F., Bröhl, D., Chang, T. H., Mademtzoglou, D., Mourikis, P., Yao, Z., Cao, Y., Birchmeier, C., et al. (2014) · Development · doi:10.1242/dev.110155 · Cited by 56
Foersch, S., Sperka, T., Lindner, C., Taut, A., Rudolph, K. L., Breier, G., Boxberger, F., Rau, T. T., Hartmann, A., Stürzl, M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.016 · Cited by 57
The role of microRNA-26a in human cancer progression and clinical application
Chen, J., Zhang, K., Xu, Y., Gao, Y., Li, C., Wang, R., & Chen, L. (2016) · Tumor Biology · doi:10.1007/s13277-016-5017-y · Cited by 57
Molecular control of cell density-mediated exit to quiescence
Fan, Y., & Meyer, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109436 · Cited by 54
Mdm2: A Regulator of Cell Growth and Death
Alarcon-Vargas, D., Takahashi, S., & Ronai, Z. A. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)01001-7 · Cited by 57
FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest
Laplantine, E., Rossi, F., Sahni, M., Basilico, C., & Cobrinik, D. E. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200205025 · Cited by 59
Ki-ras mutation and cell proliferation of lung lesions induced by 1-nitropyrene in A/J mice
Bai, F., Nakanishi, Y., Takayama, K., Pei, X., Tokiwa, H., & Hara, N. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199808)22:4 · Cited by 18
Alaoui‐Jamali, M. A., & Yen, L. (1997) · Biochemistry and Cell Biology · doi:10.1139/o97-060 · Cited by 57
Zanghi, J. A., Mendoza, T. P., Knop, R. H., & Miller, W. M. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199811)177:2 · Cited by 26
Inactivation of p21 Enhances Intestinal Tumor Formation in Muc2−/− Mice
Yang, W., Velcich, A., Lozonschi, I., Liang, J., Nicholas, C., Zhuang, M., Bancroft, L. K., & Augenlicht, L. H. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62342-5 · Cited by 57
p21CIP1 Is Dispensable for the G2 Arrest Caused by Genistein in Human Melanoma Cells
Casagrande, F., & Darbon, J.-M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4914 · Cited by 57
Moons, D. S., Jirawatnotai, S., Tsutsui, T., Franks, R. R., Parlow, A. F., Hales, D. B., Gibori, G., Fazleabas, A. T., & Kiyokawa, H. (2002) · Endocrinology · doi:10.1210/endo.143.2.8611 · Cited by 57
Bishop, A. J. R., Hollander, M. C., Kosaras, B., Sidman, R. L., Fornace, A. J., & Schiestl, R. H. (2003) · PubMed · Cited by 57
Gorospe, M., Shack, S., Guyton, K. Z., Samid, D., & Holbrook, N. J. (1996) · PubMed · Cited by 57
Seo, Y. R., & Jung, H. J. (2004) · Experimental & Molecular Medicine · doi:10.1038/emm.2004.64 · Cited by 56
Metadata
- Authors
- Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P.
- Affiliations
- Baylor College of Medicine (US)
- Howard Hughes Medical Institute (US)
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1995-08
- Volume
- 82
- Issue
- 4
- Pages
- 675-684
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2044057392
- Cited by
- 2,113
- References
- 70
- Citations by year
- 2026: 20 · 2025: 20 · 2024: 32 · 2023: 32 · 2022: 34 · 2021: 40 · 2020: 38 · 2019: 40 · 2018: 43 · 2017: 36 · 2016: 37 · 2015: 34 · 2014: 57 · 2013: 39 · 2012: 65
- FWCI
- 61.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute on Aging (AG11085, R01AG011085)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p21, p53, G1/S checkpoint, cyclin-dependent kinase inhibitors, DNA damage response, embryonic fibroblasts, cell growth, thymocyte apoptosis, mitotic spindle checkpoint, tumor suppression
- MeSH terms
- Animals, Base Sequence, Cell Differentiation, Cell Division, Cell Line, DNA, DNA Damage, Spindle Apparatus, Molecular Sequence Data, Neoplasms, Experimental, Genes, p53, Tumor Suppressor Protein p53, G1 Phase, Cyclins, Apoptosis, Cyclin-Dependent Kinase Inhibitor p21, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review